Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Pediatr Endocrinol Metab ; 15(7): 1017-25, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12199329

RESUMEN

In this retrospective study from Saudi Arabia, which is a rich and sunny country, we report our experience with 34 adolescents (20 females, 10 males) with rickets. The commonest cause was vitamin D deficiency (58.8%) followed by rickets due to low calcium intake (11.8%) and genetic causes, including possible 25-hydroxylase deficiency (8.8%). The etiology of nutritional rickets is multifactorial, including lack of sun exposure and inadequate calcium intake. The clinical symptoms were nonspecific and therefore cases in this country are either underdiagnosed or missed. Vitamin D deficient patients needed an average of 19 months of treatment before recovery. High dose vitamin D plus calcium supplementation are recommended for treatment. Measures to prevent rickets in all age groups including adolescents are suggested. Further studies on nutritional and genetic forms of rickets are recommended.


Asunto(s)
Raquitismo/etiología , Adolescente , Calcio de la Dieta/administración & dosificación , Colestanotriol 26-Monooxigenasa , Vestuario/efectos adversos , Exposición a Riesgos Ambientales , Femenino , Humanos , Hiperparatiroidismo/complicaciones , Hipofosfatemia/complicaciones , Masculino , Estudios Retrospectivos , Raquitismo/genética , Arabia Saudita , Esteroide Hidroxilasas/deficiencia , Luz Solar , Deficiencia de Vitamina D/complicaciones
2.
Birth Defects Res A Clin Mol Teratol ; 76(2): 138-42, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16470853

RESUMEN

BACKGROUND: Methotrexate (MTX) embryopathy was described nearly 50 years ago, when this agent began to be used as a cancer treatment and abortifacient. In this report we describe a case with typical features of MTX syndrome together with new features to expand the phenotype. CASE: A 29-year-old woman decided to terminate her unwanted pregnancy because of ill health, as she had conceived soon after her last delivery by cesarian section. At 6 weeks of gestation, she took 2.5 mg of MTX 3 times a day for 7 days. The pregnancy termination failed, and the pregnancy was carried to term. A female infant was delivered who was growth retarded and had characteristic features of MTX embryopathy in addition to holoprosencephaly and other brain malformations, facial hypertrichosis, and long eyelashes--features that have not hitherto been described. CONCLUSIONS: We report the first case of holoprosencephaly in association with MTX exposure during the first 6 weeks of gestation. Physicians and the public should be aware of the effects of MTX on the fetus during pregnancy.


Asunto(s)
Anomalías Inducidas por Medicamentos , Holoprosencefalia/inducido químicamente , Holoprosencefalia/embriología , Metotrexato/efectos adversos , Fenotipo , Femenino , Holoprosencefalia/fisiopatología , Humanos , Lactante
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA